Castle Biosciences Inc.

NASDAQ: CSTL · Real-Time Price · USD
19.89
0.07 (0.35%)
At close: Aug 15, 2025, 2:42 PM

Castle Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-9.47M -5.07M 18.25M 6.08M -3.1M -30.8M -57.47M -75.5M -88.85M -71.72M -67.14M -52.95M -44.49M -51.63M -31.29M -29.75M -22.55M -15.13M
Depreciation & Amortization
42.49M 42.42M 16M 13.45M 13.09M 12.78M 12.33M 11.95M 11.7M 11.28M 10.54M 9.15M 7.32M 5.33M 3.41M 2.12M 1.15M 614K
Stock-Based Compensation
46.85M 48.82M 50.32M 50.68M 50.7M 50.37M 51.22M 49.34M 45.49M 41.43M 36.32M 33.25M 29.26M 25.25M 21.74M 17.85M 14.76M 11.64M
Other Working Capital
-1.4M 427K 3.08M 6.17M 3.46M 2.77M 6.55M 4.27M 2.98M 3.9M 7.31M 4.64M 2.15M -3.98M 384K -2.08M -1.41M 8.41M
Other Non-Cash Items
-21.89M 3.29M 25.49M 31.8M 47.9M 23.83M 587K -5.13M -3.79M -23.09M -19.5M -17.89M -17.87M 2.54M n/a 55K 440K 632K
Deferred Income Tax
-2.49M 631K 1.4M 3.47M -1.75M -188K -175K 23K -9K -1.99M -1.88M -10.57M -10.57M -8.61M -8.74M 1.4M 1.4M 1.4M
Change in Working Capital
7M 398K 1.98M 7.67M -12.02M -13.78M -6.63M -10.89M -5M -1.58M -7K 573K -2.99M -9.65M -4.1M -8.3M -8.65M 7.33M
Operating Cash Flow
62.49M 65.67M 64.87M 64.58M 46.25M 18.47M -135K -30.21M -40.45M -45.66M -41.66M -38.44M -39.34M -36.78M -18.98M -16.63M -13.45M 6.49M
Capital Expenditures
-27.95M -23.91M -28.33M -24.55M -20.63M -19.43M -13.62M -11.62M -11.2M -8.57M -5.63M -4.74M -3.63M -3.13M -3.48M -3.18M -4.16M -5M
Cash Acquisitions
-18.73M 2K 7K 10K 12K 13K 13K 27.52M 27.22M 552K 547K -90.15M -123.03M -96.36M -96.36M -33.18M 2K n/a
Purchase of Investments
-185.37M -193.41M -205.73M -210.79M -215.83M -219.75M -189.07M -139.57M -221.13M -164.77M -134.69M -131.81M n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
177.75M 170M 183.9M 171.75M 177.95M 186.7M 186.5M 138M 226.81M 181.81M 131.81M 131.81M n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-5.54M -21.74M -26.73M -30.61M -37.87M -33.03M -2.56M -26.01M -150.56M -138.66M -158.58M -98.06M 33.75M 10K 10K -33.18M -33.18M 3K
Investing Cash Flow
-59.83M -52.87M -50.14M -63.58M -58.5M -52.47M -16.18M -12.99M -137.44M -149.56M -166.54M -192.95M -59.73M -66.31M -66.66M -36.36M -37.34M -5M
Debt Repayment
-133K -87K 9.9M 9.89M 9.88M 9.86M -142K -140K -137K -133K -122K -88K -55K -24K n/a -24.03M -26.53M -26.53M
Common Stock Repurchased
1.09M 474K n/a -4.01M -5.38M -5.29M -5.13M -2.67M -2.45M -1.95M -1.69M -915K -869K -837K -781K n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-7.85M -7.93M -5.71M -3.24M -2.45M -2.24M -2.16M 389K 729K 1.16M 1.64M 3.26M 4.73M 5.93M 6.2M 6.6M 5.39M 72.86M
Financial Cash Flow
-6M -6.06M 6.14M 8.23M 7.43M 7.62M -2.3M 249K 592K 1.03M 1.51M 2.39M 3.9M 5.13M 5.42M 233.12M 239.37M 306.84M
Net Cash Flow
-3.34M 6.74M 20.87M 3.74M -10.3M -31.87M -24.11M -42.96M -177.29M -194.2M -206.69M -229M -95.17M -97.96M -80.22M 180.13M 188.58M 308.33M
Free Cash Flow
34.54M 41.75M 36.54M 40.03M 25.62M -966K -13.76M -41.83M -51.65M -54.23M -47.29M -43.17M -42.97M -39.92M -22.47M -19.81M -17.61M 1.48M